PDL BioPharma Inc (NASDAQ:PDLI)

6.66
Delayed Data
As of May 22
 +0.02 / +0.30%
Today’s Change
6.38
Today|||52-Week Range
10.26
-13.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues164.8M165.6M117.1M149.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses6.9M5.7M17.7M7.7M
 
 
 
 
 
Total Operating Expenses6.9M5.7M17.7M7.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income157.9M159.9M99.3M141.4M
 
 
 
 
 
Extraordinary Credit0.002.0K0.000.00
 
 
Interest Expense On Debt9.9M9.4M9.4M8.6M
 
 
 
 
 
Other Expenses-2.0M-989.0K0.00755.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income146.1M149.6M90.0M133.5M
 
 
 
 
 
Income Taxes-54.0M-47.4M-34.9M-49.0M
 
 
 
 
 
Net Income92.1M102.2M55.1M84.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS160.3M160.3M161.2M162.8M
 
 
 
 
 
Shares To Calculate EPS Diluted177.2M166.9M169.9M170.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.52$0.61$0.32$0.50
 
 
 
 
 
EPS Diluted$0.52$0.61$0.32$0.50
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account